OVERVIEW
The Global Rat Model Market is expected to hit USD 748.25 million by 2025, rising by 7.91% to CAGR during the forecast period. Factors such as Continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized rat models, Advancements in gene editing tools set to augment the demand for rat models are driving demand for Rat Model Market.
TABLE OF CONTENT
1 Global Rat Model Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Rat Model Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Rat Model Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Rat Model Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Rat Model Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Rat Model Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Rat Model Market – By Model Type (Market Size – & million/billion)
8.1 Outbred Rats
8.2 Inbred Rats
8.3 Conditioned/Surgically Modified Rats
8.4 Immunodeficient Rats
8.5 Knockout/Genetically Modified Rats
8.6 Hybrid/Congenic Rats
9 Global Rat Model Market – By Therapeutic Area
9.1 Toxicology
9.2 Oncology
9.3 Immunology and Inflammation
9.4 Neurology
9.5 Diabetes
9.6 Others
10 Global Rat Model Market – By End User
10.1 Pharmaceutical & Biotechnology Companies
10.2 Academic & Research Institutes
10.3 Contract Research Organizations (CROs)
11 Global Rat Model Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Rat Model Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Rat Model Market -Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Charles River Laboratories International, Inc.
13.3 Taconic Biosciences, Inc.
13.4 Envigo
13.5 Laboratory Corporation of America Holdings
13.6 Janvier Labs
13.7 Genoway S.A.
13.8 Biomere
13.9 Transposagen Biopharmaceuticals, Inc.
13.10 Horizon Discovery Group PLC
13.11 Transviragen, Inc.
13.12 Company 11 & more
14 Global Rat Model Market – Appendix
14.1 Sources
14.2 Abbreviations